Qingdao Baheal Medical INC. (SHE:301015)
China flag China · Delayed Price · Currency is CNY
25.68
+0.64 (2.56%)
Sep 30, 2026, 3:04 PM CST

SHE:301015 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Cash & Equivalents
1,7722,1371,4671,3441,0481,276
Trading Asset Securities
397.03264.4644.9927.6227.2240.77
Cash & Short-Term Investments
2,1692,4021,5121,3721,0751,317
Cash Growth
8.74%58.81%10.23%27.63%-18.38%15.32%
Accounts Receivable
1,5311,9602,2162,4642,2321,943
Other Receivables
67.6876.44161.58214.7844.4341.34
Receivables
1,5982,0362,3772,6792,2771,984
Inventory
1,176895.57927.75861.67650.1623.85
Prepaid Expenses
----0.60.55
Other Current Assets
501.39383.94293.35205.94255.48165.91
Total Current Assets
5,4455,7185,1115,1184,2584,092
Property, Plant & Equipment
903.35885.47810.65672.15432.99225.75
Long-Term Investments
1,046901.78742.62263.95181.57151.71
Goodwill
112.49112.49112.49107.60.695.96
Other Intangible Assets
260.65227.52227.59140.0956.7728.65
Long-Term Deferred Tax Assets
89.4486.7858.176.5736.6532.85
Long-Term Deferred Charges
71.9476.740.7334.318.018.3
Other Long-Term Assets
53.4103.89.434.555.6158.02
Total Assets
7,9828,1127,1136,4175,0304,603

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Accounts Payable
850.681,2191,1631,072990.3845.76
Accrued Expenses
287.41308.27229.97206.1211.14138.26
Short-Term Debt
2,3311,9321,099513.021,1651,189
Current Portion of Long-Term Debt
50.0250.6943.4161.44--
Current Portion of Leases
27.6134.2627.8720.7827.3415.42
Current Income Taxes Payable
39.2554.6464.78101.4733.9932.52
Current Unearned Revenue
157.39146.65118.5297.892.48113.78
Other Current Liabilities
65.7232.03512.32319.0683.5466.32
Total Current Liabilities
3,8093,9773,2582,3922,6042,401
Long-Term Debt
1,3151,2531,113771.93--
Long-Term Leases
99.03109.6102.5687.41145.3422.21
Long-Term Unearned Revenue
1212.9111.4313.6--
Long-Term Deferred Tax Liabilities
16.7217.3418.3933.541.135.85
Other Long-Term Liabilities
--5---
Total Liabilities
5,2525,3704,5083,2982,7502,429

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Common Stock
525.62525.62525.62525.61525.1525.1
Additional Paid-In Capital
24.3416.31-653.47411.61418.31
Retained Earnings
1,7491,8251,7501,6101,3641,212
Comprehensive Income & Other
95.6496.6798.91101.631.652.11
Total Common Equity
2,3952,4632,3752,8912,3022,157
Minority Interest
335.68278.7229.76228.4-22.1116.76
Shareholders' Equity
2,7302,7422,6053,1192,2802,174
Total Liabilities & Equity
7,9828,1127,1136,4175,0304,603

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Jan '22
Total Debt
3,8233,3802,3851,4551,3381,226
Net Cash (Debt)
-1,654-978.05-872.59-82.51-262.7190.77
Net Cash Growth
------
Net Cash Per Share
-3.08-1.83-1.61-0.15-0.500.18
Filing Date Shares Outstanding
525.62525.62525.62519.55525.1525.1
Total Common Shares Outstanding
525.62525.62525.62519.55525.1525.1
Working Capital
1,6351,7401,8532,7271,6541,691
Book Value Per Share
4.564.694.525.564.384.11
Tangible Book Value
2,0222,1232,0352,6432,2452,123
Tangible Book Value Per Share
3.854.043.875.094.274.04
Buildings
611.4608.41504.28464.74206.13206.13
Machinery
547.36544.22450.97338.9691.278.02
Construction In Progress
125.8467.69152.26143.2980.58.78